Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML)

t(8;21)(q22;q22) is present in ~5–10% of patients with de novo acute myeloid leukemia (AML) and is associated with a better overall prognosis. Variants of the t(8;21) have been described in the literature, however, their clinical and prognostic significance has not been well-characterized. Molecular...

Full description

Bibliographic Details
Main Authors: Lindsay Wilde, Jillian Cooper, Zi-Xuan Wang, Jinglan Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01016/full
_version_ 1828835381346304000
author Lindsay Wilde
Jillian Cooper
Zi-Xuan Wang
Zi-Xuan Wang
Jinglan Liu
author_facet Lindsay Wilde
Jillian Cooper
Zi-Xuan Wang
Zi-Xuan Wang
Jinglan Liu
author_sort Lindsay Wilde
collection DOAJ
description t(8;21)(q22;q22) is present in ~5–10% of patients with de novo acute myeloid leukemia (AML) and is associated with a better overall prognosis. Variants of the t(8;21) have been described in the literature, however, their clinical and prognostic significance has not been well-characterized. Molecular profiling of these cases has not previously been reported but may be useful in better defining the prognosis of this subset of patients. We present two cases of variant t(8;21) AML including clinical, cytogenetic, and molecular data.
first_indexed 2024-12-12T18:00:58Z
format Article
id doaj.art-db32e7aad06c4dc5b5c260a06c673f0a
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-12T18:00:58Z
publishDate 2019-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-db32e7aad06c4dc5b5c260a06c673f0a2022-12-22T00:16:37ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2019-10-01910.3389/fonc.2019.01016473019Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML)Lindsay Wilde0Jillian Cooper1Zi-Xuan Wang2Zi-Xuan Wang3Jinglan Liu4Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United StatesDepartment of Internal Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, United StatesDepartment of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, PA, United StatesDepartment of Surgery, Thomas Jefferson University Hospital, Philadelphia, PA, United StatesDepartment of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University Hospital, Philadelphia, PA, United Statest(8;21)(q22;q22) is present in ~5–10% of patients with de novo acute myeloid leukemia (AML) and is associated with a better overall prognosis. Variants of the t(8;21) have been described in the literature, however, their clinical and prognostic significance has not been well-characterized. Molecular profiling of these cases has not previously been reported but may be useful in better defining the prognosis of this subset of patients. We present two cases of variant t(8;21) AML including clinical, cytogenetic, and molecular data.https://www.frontiersin.org/article/10.3389/fonc.2019.01016/fullacute myeloid leukemiat(8;21)cytogeneticscore binding factorvariant
spellingShingle Lindsay Wilde
Jillian Cooper
Zi-Xuan Wang
Zi-Xuan Wang
Jinglan Liu
Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML)
Frontiers in Oncology
acute myeloid leukemia
t(8;21)
cytogenetics
core binding factor
variant
title Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML)
title_full Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML)
title_fullStr Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML)
title_full_unstemmed Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML)
title_short Clinical, Cytogenetic, and Molecular Findings in Two Cases of Variant t(8;21) Acute Myeloid Leukemia (AML)
title_sort clinical cytogenetic and molecular findings in two cases of variant t 8 21 acute myeloid leukemia aml
topic acute myeloid leukemia
t(8;21)
cytogenetics
core binding factor
variant
url https://www.frontiersin.org/article/10.3389/fonc.2019.01016/full
work_keys_str_mv AT lindsaywilde clinicalcytogeneticandmolecularfindingsintwocasesofvariantt821acutemyeloidleukemiaaml
AT jilliancooper clinicalcytogeneticandmolecularfindingsintwocasesofvariantt821acutemyeloidleukemiaaml
AT zixuanwang clinicalcytogeneticandmolecularfindingsintwocasesofvariantt821acutemyeloidleukemiaaml
AT zixuanwang clinicalcytogeneticandmolecularfindingsintwocasesofvariantt821acutemyeloidleukemiaaml
AT jinglanliu clinicalcytogeneticandmolecularfindingsintwocasesofvariantt821acutemyeloidleukemiaaml